AstraZeneca PLC Files 6-K Report
Ticker: AZN · Form: 6-K · Filed: Aug 12, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | Aug 12, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-issuer
Related Tickers: AZN
TL;DR
AZN filed a 6-K, confirming 20-F reporting. Standard stuff.
AI Summary
AstraZeneca PLC filed a Form 6-K on August 12, 2025, reporting its status as a foreign issuer. The filing confirms that AstraZeneca is submitting its annual reports under Form 20-F. The company's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
Why It Matters
This filing is a routine regulatory submission for foreign issuers, confirming their reporting structure with the SEC and providing updated corporate information.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a large, established company and does not contain new material financial or operational information.
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the report
- 001-11960 (company) — SEC File Number
- 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom (company) — Business and mail address
- ZENECA GROUP PLC (company) — Former company name
- 19930422 (date) — Date of name change from ZENECA GROUP PLC
- 20250812 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer submitted to the SEC pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, typically used to provide information that the registrant makes or is required to make public in its home country.
Which form does AstraZeneca PLC use for its annual reports?
AstraZeneca PLC indicates it files its annual reports under cover of Form 20-F.
What is AstraZeneca PLC's SEC file number?
AstraZeneca PLC's SEC file number is 001-11960.
Where are AstraZeneca PLC's principal executive offices located?
AstraZeneca PLC's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
When was AstraZeneca PLC formerly known as ZENECA GROUP PLC?
AstraZeneca PLC was formerly known as ZENECA GROUP PLC, with the date of name change being April 22, 1993 (19930422).
Filing Stats: 1,116 words · 4 min read · ~4 pages · Grade level 9.8 · Accepted 2025-08-12 10:45:07
Filing Documents
- a0142v.htm (6-K) — 73KB
- 0001654954-25-009396.txt ( ) — 74KB
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     AstraZeneca PLC     Date: 12 August 2025     By: /s/ Matthew Bowden   Name: Matthew Bowden   Title: Company Secretary